{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:30:07Z","timestamp":1771626607528,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"DOI":"10.7759\/cureus.103992","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:31:01Z","timestamp":1771623061000},"source":"Crossref","is-referenced-by-count":0,"title":["Premature Coronary Artery Disease and Familial Dyslipidemia in Patients Presenting With Acute Coronary Syndrome: A Tertiary Cardiac Center Registry"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Saad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Elgazzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Senara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham S","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2004.09.025","article-title":"Heart disease epidemic in Pakistan: women and men at equal risk","volume":"150","author":"Jafar TH","year":"2005","unstructured":"Jafar TH, Jafary FH, Jessani S, Chaturvedi N. Heart disease epidemic in Pakistan: women and men at equal risk. Am Heart J. 2005, 150:221-6.","journal-title":"Am Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard BG","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, et al.. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013, 34:3478-90a. 10.1093\/eurheartj\/eht273","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel M","year":"2014","unstructured":"Cuchel M, Bruckert E, Ginsberg HN, et al.. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J. 2014, 35:2146-57. 10.1093\/eurheartj\/ehu274","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn M","year":"2016","unstructured":"Benn M, Watts GF, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Eur Heart J. 2016, 37:1384-94. 10.1093\/eurheartj\/ehw028","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","volume":"4","author":"Santos RD","year":"2016","unstructured":"Santos RD, Gidding SS, Hegele RA, et al.. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. Lancet Diabetes Endocrinol. 2016, 4:850-61. 10.1016\/S2213-8587(16)30041-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf7000","article-title":"Genetic identification of familial hypercholesterolemia within a single U.S. health care system","volume":"354","author":"Abul-Husn NS","year":"2016","unstructured":"Abul-Husn NS, Manickam K, Jones LK, et al.. Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science. 2016, 354:10.1126\/science.aaf7000","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.297","article-title":"Association of socioeconomic position with health behaviors and mortality","volume":"303","author":"Stringhini S","year":"2010","unstructured":"Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, Singh-Manoux A. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010, 303:1159-66. 10.1001\/jama.2010.297","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen K","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth universal definition of myocardial infarction (2018). Circulation. 2018, 138:e618-51. 10.1161\/CIR.0000000000000617","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez B","year":"2018","unstructured":"Ibanez B, James S, Agewall S, et al.. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018, 39:119-77. 10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"key":"ref10","article-title":"Definition and application of performance specifications for measurement uncertainty of 23 common laboratory tests: linking theory to daily practice","volume":"612","author":"Braga F","year":"2023","unstructured":"Braga F, Pasqualetti S, Borrillo F, et al.. Definition and application of performance specifications for measurement uncertainty of 23 common laboratory tests: linking theory to daily practice. Clin Chem Lab Med. 2023, 612:213-23.","journal-title":"Clin Chem Lab Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law MR","year":"2003","unstructured":"Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003, 326:1423. 10.1136\/bmj.326.7404.1423","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00289.x","article-title":"Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia","volume":"58","author":"Davidson MH","year":"2004","unstructured":"Davidson MH, Ballantyne CM, Kerzner B, et al.. Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia. Int J Clin Pract. 2004, 58:746-55. 10.1111\/j.1368-5031.2004.00289.x","journal-title":"Int J Clin Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960181107","article-title":"Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia","volume":"18","author":"Bruckert E","year":"1995","unstructured":"Bruckert E, De Gennes JL, Malbecq W, Baigts F. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Clin Cardiol. 1995, 18:621-9. 10.1002\/clc.4960181107","journal-title":"Clin Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.11.004","article-title":"Effects of coadministered extended-release niacin\/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia","volume":"6","author":"Ballantyne C","year":"2012","unstructured":"Ballantyne C, Gleim G, Liu N, Sisk CM, Johnson-Levonas AO, Mitchel Y. Effects of coadministered extended-release niacin\/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia. J Clin Lipidol. 2012, 6:235-43. 10.1016\/j.jacl.2011.11.004","journal-title":"J Clin Lipidol"},{"key":"ref15","article-title":"Compliance and efficacy of pravastatin and cholestyramine treatment","volume":"243","author":"Eriksson M","year":"1998","unstructured":"Eriksson M, H\u00e5dell K, Holme I, et al.. Compliance and efficacy of pravastatin and cholestyramine treatment. J Intern Med. 1998, 243:373-80.","journal-title":"J Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.037137","article-title":"Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction","volume":"139","author":"Arora S","year":"2019","unstructured":"Arora S, Stouffer GA, Kucharska-Newton AM, et al.. Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019, 139:1047-56. 10.1161\/CIRCULATIONAHA.118.037137","journal-title":"Circulation"},{"key":"ref17","article-title":"Gender differences in coronary heart disease","volume":"18","author":"Maas AH","year":"2010","unstructured":"Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J. 2010, 18:598-603.","journal-title":"Neth Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (INTERHEART)","volume":"364","author":"Yusuf S","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al.. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (INTERHEART). Lancet. 2004, 364:937-52. 10.1016\/S0140-6736(04)17018-9","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.6995","article-title":"General cardiovascular risk profile for use in primary care","volume":"117","author":"D\u2019Agostino RB","year":"2008","unstructured":"D\u2019Agostino RB, Vasan RS, Pencina MJ, et al.. General cardiovascular risk profile for use in primary care. Circulation. 2008, 117:743-53. 10.1161\/CIRCULATIONAHA.107.6995","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.007","article-title":"Cardiovascular risk and statin eligibility of young adults after myocardial infarction: the YOUNG-MI registry","volume":"71","author":"Singh A","year":"2018","unstructured":"Singh A, Collins BL, Gupta A, et al.. Cardiovascular risk and statin eligibility of young adults after myocardial infarction: the YOUNG-MI registry. J Am Coll Cardiol. 2018, 71:292-302. 10.1016\/j.jacc.2017.11.007","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn M","year":"2012","unstructured":"Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012, 97:3956-64. 10.1210\/jc.2012-1563","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes","volume":"67","author":"Khera AV","year":"2016","unstructured":"Khera AV, Won HH, Peloso GM, et al.. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes. J Am Coll Cardiol. 2016, 67:2578-89. 10.1016\/j.jacc.2016.03.520","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.04.003","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg AC","year":"2011","unstructured":"Goldberg AC, Hopkins PN, Toth PP, et al.. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011, 5:S1-8. 10.1016\/j.jacl.2011.04.003","journal-title":"J Clin Lipidol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti J","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al.. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020, 41:407-77. 10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA multisociety guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy SM","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al.. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA multisociety guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019, 139:e1082-143. 10.1161\/CIR.0000000000000625","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.15829\/1560-4071-2022-5058","article-title":"Association of various lipid parameters with premature coronary artery disease in men","volume":"27","author":"Tyurina AV","year":"2022","unstructured":"Tyurina AV, Kukharchuk VV, Soloveva EY, et al.. Association of various lipid parameters with premature coronary artery disease in men. Russ J Cardiol. 2022, 27:5058. 10.15829\/1560-4071-2022-5058","journal-title":"Russ J Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803917","article-title":"Safety and efficacy of bempedoic acid to reduce LDL cholesterol","volume":"380","author":"Ray KK","year":"2019","unstructured":"Ray KK, Bays HE, Catapano AL, et al.. Safety and efficacy of bempedoic acid to reduce LDL cholesterol. N Engl J Med. 2019, 380:1022-32. 10.1056\/NEJMoa1803917","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding SS","year":"2015","unstructured":"Gidding SS, Champagne MA, de Ferranti SD, et al.. The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association. Circulation. 2015, 132:2167-92. 10.1161\/CIR.0000000000000297","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman A","year":"2015","unstructured":"Wiegman A, Gidding SS, Watts GF, et al.. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015, 36:2425-37. 10.1093\/eurheartj\/ehv157","journal-title":"Eur Heart J"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000228","article-title":"Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association","volume":"132","author":"Havranek EP","year":"2015","unstructured":"Havranek EP, Mujahid MS, Barr DA, et al.. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015, 132:629-52. 10.1161\/CIR.0000000000000228","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455958-premature-coronary-artery-disease-and-familial-dyslipidemia-in-patients-presenting-with-acute-coronary-syndrome-a-tertiary-cardiac-center-registry","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:31:02Z","timestamp":1771623062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455958-premature-coronary-artery-disease-and-familial-dyslipidemia-in-patients-presenting-with-acute-coronary-syndrome-a-tertiary-cardiac-center-registry"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.103992","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}